Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date19 Apr 1949 |
100 Clinical Results associated with Xttrium Laboratories, Inc.
0 Patents (Medical) associated with Xttrium Laboratories, Inc.
100 Deals associated with Xttrium Laboratories, Inc.
100 Translational Medicine associated with Xttrium Laboratories, Inc.